Screener
Ibotta IBTA Capitalized research and development
Capitalized research and development at other companies
Other financials
Where this comes from
Reported directly by Ibotta in its filing.
Tagged under the XBRL concept ibta:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts.
The source filing: Ibotta’s 10-K, filed February 26, 2026.
- Filed
- Feb 25, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-011838
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Net operating loss, credit carryforwards | $22,402 | $19,533 |
| Accruals and reserves | 8,888 | 9,640 |
| User redemption liability | 8,503 | 9,630 |
| Capitalized research and development | 22,653 | 39,031 |
| Other deferred tax assets | 6,815 | — |
| Gross deferred tax assets | 69,261 | 77,834 |
| Deferred tax liabilities: | ||
| Property and equipment | (10,793) | (3,416) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Ibotta's capitalized research and development?
- Ibotta (IBTA) reported capitalized research and development of $22.65M in Q4 2025.
- What is the long-term trend for Ibotta's capitalized research and development?
- Over 2 years (2023 to 2025), Ibotta's capitalized research and development has grown at a -13.5% compound annual growth rate (CAGR), from $30.29M to $22.65M.
- What does capitalized research and development mean?
- This represents the portion of research and development expenditures that have been capitalized as an asset rather than expensed immediately in the period incurred. Capitalization occurs when costs meet specific criteria for future economic benefit, such as software development for internal use or platform enhancements. This metric provides insight into the company's investment in long-term innovation and technology infrastructure.
Ask your AI about Ibotta's capitalized research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude